Okay, let's tackle this question about the major source of collagen in cirrhosis. First, I need to recall the pathophysiology of liver cirrhosis. Cirrhosis is characterized by the replacement of healthy liver tissue with fibrous scar tissue, leading to loss of liver function. The key players here are the hepatic stellate cells (HSCs), which are activated during liver injury.

So, the question is asking about the major source of collagen in this condition. In a healthy liver, HSCs store vitamin A, but when there's injury, they become activated. Activated HSCs transform into myofibroblasts, which produce excessive collagen, particularly type I and III. This overproduction leads to the fibrosis seen in cirrhosis.

Now, looking at the options, even though they aren't listed, the correct answer is likely to be hepatic stellate cells. The other options might include things like Kupffer cells, hepatocytes, or fibroblasts. Kupffer cells are macrophages involved in phagocytosis, not collagen production. Hepatocytes are the main functional cells of the liver but don't produce collagen in cirrhosis. Fibroblasts are present in other tissues but in the liver, the primary source is HSCs.

A clinical pearl here is that targeting HSCs is a focus for antifibrotic therapies. Remembering that HSCs are the main collagen producers in liver fibrosis is crucial for exams. So the correct answer should be the one that refers to hepatic stellate cells.

**Core Concept**
In liver cirrhosis, excessive extracellular matrix deposition occurs due to activation of **hepatic stellate cells (HSCs)**. These cells transition from a quiescent vitamin A-storing state to a myofibroblastic phenotype, secreting collagen types I and III, which drive fibrosis.

**Why the Correct Answer is Right**
Activated **hepatic stellate cells** are the primary source of collagen in cirrhosis. During chronic liver injury (e.g., from hepatitis, alcohol), HSCs undergo transdifferentiation into myofibroblasts, upregulating **α-smooth muscle actin** and secreting **excessive collagen** via **TGF-β signaling**. This leads to fibrous scar formation, replacing normal liver architecture and impairing function.

**Why Each Wrong Option is Incorrect**
**Option A:** *Kupffer cells* are resident macrophages involved in immune responses and phagocytosis, not collagen synthesis.
**Option B:** *Hepatocytes* are the primary functional cells of the liver but do not produce collagen in cirrhosis.
**Option C:** *Portal fibroblasts* contribute minimally to fibrosis compared to activated HSCs.

**Clinical Pearl / High-Yield Fact**
Targeting **hepatic stellate cell activation** is a key therapeutic strategy in antifibrotic drug development. Remember: **HSCs = collagen overproducers in liver fibrosis**—a classic exam trap is confusing HSCs with Kupffer cells.

**Correct Answer: C. Hepatic stellate cells**

✓ Correct Answer: B. Ito cell (Hepatic stellate cell)